Since 1988, Burns McClellan has provided strategic public and investor relations services to the international life sciences and healthcare community. As a communications consultancy, we advise companies who specialize in pharmaceutical discovery and development, drug delivery, medical devices and diagnostics, as well as advisory and investment firms focusing on the biotechnology industry.
The agency’s staff of professionals is experienced in all facets of life sciences communication. Staff members have proven track records in medical research, finance and investing, marketing communications, regulatory affairs and related disciplines.
Based in New York City, Burns McClellan provides access to global markets through our partnership with Optimum Strategic Communications, a European communications firm specializing in PR, IR, public affairs, corporate and financial communications.